SINTX Technologies prices $1.5M public offering of 71.6M shares at $0.021/share

Sintx Technologies, Inc.

Priced public offering of 71.6M shares at $0.021/share for gross proceeds of ~$1.5M.
Offering expected to close April 5, 2024; Maxim Group LLC acting as sole placement agent.
Net proceeds to be used for working capital and general corporate purposes.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Sintx Technologies, Inc. entered into Purchase Agreement with certain investors named therein (the "Purchasers") valued at approximately $1.5 million (effective 2024-04-03).

Action: entry
Agreement: equity purchase
Counterparty: certain investors named therein (the "Purchasers")
Value: approximately $1.5 million
Effective: 2024-04-03

Exact text from the filing

On April 3, 2024, SINTX Technologies, Inc. (the “Company”) entered into a stock purchase agreement (the “Purchase Agreement”) with certain investors named therein (the “Purchasers")

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Sintx Technologies, Inc. entered into PAA with Maxim Group LLC (the "Placement Agent") (effective 2024-04-03).

Action: entry
Agreement: underwriting
Counterparty: Maxim Group LLC (the "Placement Agent")
Effective: 2024-04-03

Exact text from the filing

PAA”) with Maxim Group LLC (the “Placement Agent”), pursuant to which the Company agreed to issue and sell to the Purchasers an aggregate of 71,600,000 shares (the “Shares”) of the Company’s common stock, par value $0.01 per

View on SEC.gov

419 material agreements filed in the last 30 days. Browse all material agreements →

Sintx Technologies, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-013226

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.